glp 1 agonist mechanism Possible mechanisms of action of glucagon-like peptide-1 receptor agonists on blood pressure beyond body weight Evolution of GLP‐1 Receptor Agonists
Description
It improves the separation of structural isomers that share identical masses
Douton et al
Differential regulation of the glucagon and insulin I gene promoters by the basic helix-loop-helix transcription factors E47 and BETA2
Benefits of GLP-1 therapy: Non-invasive Average weight loss: 1020% (depending on medication) Improved blood sugar control, lower cholesterol, and reduced cardiovascular risk Some patients achieve remission of type 2 diabetes Common side effects: Nausea, vomiting, diarrhea, constipation Rare gallbladder or pancreas-related issues Possible muscle loss if weight loss happens too quickly without proper exercise Considerations GLP-1 medications require continuous use to maintain weight loss
Treating Fatty Liver Disease: GLP-1 receptor agonists have shown promise in managing non-alcoholic fatty liver disease
10.1177/1479164111436236 97 KarimA.LaurentA.MunsakaM.WannE.FleckP.MekkiQ
